Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • January 2002 | Volume 15 - Issue 1
    By Michael Metzger, DPM, MBA
    12,727 reads | 0 comments | 09/03/08
    Whether you are a new practitioner opening your first office or a veteran DPM setting up shop in a new location, having an effective business plan is a necessity. The business plan is a promotional selling document. Indeed, it is a major tool for selling your business to a banker. It is to the banker what the history and physical are for physicians.Since a major audience for your business plan consists of higher-ups at the bank, the black and white of your plan is far more important than a winning personality. Gone are the days when you could stroll into the bank, say you are going to do the... continue reading
    Here is a lateral radiograph of a midfoot Charcot deformity with recurrence after an attempted surgical reconstruction.
    By William Scott Rogers
    13,908 reads | 0 comments | 09/03/08
    When managing patients in the acute phase of Charcot neuroarthropathy, the hallmark of treatment is immobilization and non-weightbearing of the affected foot until the destructive nature of this stage disappears and the coalescence stage begins. In the past decade, researchers have hypothesized that using bisphosphonates in acute Charcot patients can decrease pathological fractures and permanent deformity, which commonly occur in these patients.If this is true, then using bisphosphonates may also lead to less deformity, shorter treatment time, a decreased need for revisional surgery, decreased... continue reading